MSLs Activities & Best Practices

MSLs Activities & Best Practices

Jean-Michel Peny Jean-Michel Peny

Jean-Michel Peny

Founder & President @ Smart Pharma Consulting

发布日期: 2023年5月9日
+ 关注

In this position paper – the first of our 2023 Medical Series – we provide insights and recommendations re.:

  • MSLs activities planning
  • MSLs coordination with other Pharma companies’ departments
  • The way to keep regular interactions with KOLs
  • Possible evolutions of MSLs role.

In case you missed them, since the beginning of the year, we have released the following publications:

  1. “The Smart Pharma Complete Collection 2016 – 2022” – Collection of position papers
  2. “Is France Attractive for Pharma Companies - Comparisons & Recommendations” – Position paper
  3. “Five Insights about the Pharma Industry” – Position paper
  4. “The French Pharma Market 2022 - 2027 - Strategic Implications for Pharma companies” – Excerpts of a 329-page report (Order form)

If you want to know more about our Consulting & Training services, contact us!

Best regards,

Ghislain Lauzin

Business Intelligence & Business Development

1 年

Hi, Very interesting report! In slide 17 it is mentioned that for MSLs in spain: "In some regions, remote interactions are forbidden". Can you please share the official source of such an information ? Thanks in advance and thanks again for publishing such interesting information

赞
回复
1 次回应
Thomas PICHON

Life Sciences VC | ESCP Business School - Sorbonne University

1 年

Hugo Brajer ?a pourrait t'intéresser (?)

赞
回复
1 次回应
查看更多评论

要查看或添加评论，请登录

Jean-Michel Peny的更多文章

社区洞察

其他会员也浏览了